oasis 1 oral semaglutide 50 mg obesity lancet 2023 514 Hotcakes: Semaglutide, Fish Oil in ESRD, IV Iron During Infection, New US Dietary Guidelines, & Anticoagulation after Ablation in AFib GLP-1 Receptor Agonists for Weight

Anodyne's lead program, ANN-101, is a once-weekly GLP-1 patch for obesity

GLP-1 treatment can be an important healthcare decision, and consumers deserve simple, transparent information about how providers compare, what medications may be available, what costs to expect, and what signs indicate a legitimate, medically supervised program

Detecting monogenic obesity: a systematic exome-wide workup of over 500 individuals

It should be considered for patients who are obese or overweight with other risk factors where cardiovascular disease is their leading cause of disability and death. Wong does have a working relationship with multiple vendors, including Novo Nordisk

doi: 10.1038/npp.2015.85 83 HoefferC